Tag: EuroPCR 2024
Myval THV demonstrates non-inferiority in LANDMARK trial
Meril Life Sciences' Myval THV Series reveals promising outcomes, signaling potential shift in interventional cardiology practices in EuroPCR 2024 Study
GENESIS-II Study reveals exceptional 30-day results for the Hydra self-expanding transcatheter...
Findings presented at EuroPCR 2024 showcase the exceptional safety and efficacy of the Hydra THV, offering renewed hope for patients with severe aortic stenosis